Research Topics
Genomes and GenesSpecies | G M DanovitchSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of TransplantationGabriel M Danovitch
Division of Nephrology, University of California, Los Angeles, School of Medicine, Los Angeles, California 90025, USA
J Am Soc Nephrol 13:528-35. 2002....- Evaluation of adult kidney transplant candidatesSuphamai Bunnapradist
Division of Nephrology, UCLA Medical Center, Los Angeles, USA
Am J Kidney Dis 50:890-8. 2007 - The Declaration of Istanbul--early impact and future potentialGabriel M Danovitch
Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1689, USA
Nat Rev Nephrol 8:358-61. 2012..In China, however, the use of organs from executed prisoners for transplantation purposes continues despite widespread condemnation of this practice... - Challenges in the counseling and management of older kidney transplant candidatesGabriel Danovitch
Kidney Transplant Program, Division of Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095 1686, USA
Am J Kidney Dis 47:S86-97. 2006.... - Current status of kidney and pancreas transplantation in the United States, 1994-2003Gabriel M Danovitch
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
Am J Transplant 5:904-15. 2005..The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period... - A kidney for all agesG M Danovitch
Division of Nephrology, David Geffen School of Medicine at UCLA, 7-155 Factor Building, Los Angeles, CA 90095-1689, USA
Am J Transplant 6:1267-8. 2006 - Kidney vending: the "Trojan horse" of organ transplantationGabriel M Danovitch
David Geffen School of Medicine at UCLA, Division of Nephrology, Los Angeles, CA 90095-1689, USA
Clin J Am Soc Nephrol 1:1133-5. 2006 - Allocation of deceased donor kidneys: past, present, and futureGabriel M Danovitch
Department of Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA 90095 1689, USA
Am J Kidney Dis 42:882-90. 2003..They also have practical implications for the management of patients on the waiting list. The rationale behind these changes is discussed in the context of the ethical underpinnings of kidney allocation... - Immunosuppression of the elderly kidney transplant recipientGabriel M Danovitch
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Transplantation 84:285-91. 2007..Taking these factors into consideration, we propose an approach to immunosuppression in the elderly based on individual risk stratification of treatment failure and the potential for adverse events... - Cultural barriers to kidney transplantation: a new frontierGabriel M Danovitch
Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
Transplantation 84:462-3. 2007 - Mycophenolate mofetil: a decade of clinical experienceGabriel M Danovitch
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1689, USA
Transplantation 80:S272-4. 2005 - The prohibition of kidney sales and organ markets should remainGabriel M Danovitch
Kidney and Pancreas Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Curr Opin Organ Transplant 13:386-94. 2008..We encourage the investment in innovative healthy transplant practice for the benefit of all... - Cash, rewards, and benefits in organ transplantation: an open letter to Senator Arlen SpecterGabriel Danovitch
David Geffen School of Medicine at UCLA, Los Angeles, California 90096 1689, USA
Curr Opin Organ Transplant 14:129-33. 2009.... - Disparities in the utilization of live donor renal transplantationJ L Gore
VA Greater Los Angeles Healthcare System, Robert Wood Johnson Clinical Scholars Program, Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
Am J Transplant 9:1124-33. 2009..We identified significant racial and socioeconomic disparities in the utilization of LDRT. Educational initiatives and dissemination of processes that enable increased utilization of LDRT may address these disparities... - Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patientsM Z Molnar
Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, USA
Am J Transplant 11:725-36. 2011..Transplant-waitlisted hemodialysis patients with lower BMI or muscle mass and/or unintentional weight or muscle loss have higher mortality in this observational study. Impact of intentional weight change remains unclear... - Outcomes of kidney transplantation from older living donors to older recipientsJagbir Gill
Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Am J Kidney Dis 52:541-52. 2008..As waiting times for a deceased donor kidney increase, these older candidates are disadvantaged by rapidly deteriorating health, often resulting in death or removal from the wait list before transplantation... - Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel conceptF K Butt
Department of Surgery, UCLA, Los Angeles, CA, USA
Am J Transplant 9:2180-5. 2009.... - Transplant tourism in the United States: a single-center experienceJagbir Gill
Division of Nephrology, David Geffen School of Medicine at University of California, Los Angeles, California, USA
Clin J Am Soc Nephrol 3:1820-8. 2008..Median follow-up time was 487 d (range 68 to 3056)... - The medical evaluation of living kidney donors: a survey of US transplant centersD A Mandelbrot
Department of Medicine, The Transplant Center, Beth Israel Deaconess Medical Center, Boston, MA, USA
Am J Transplant 7:2333-43. 2007..These findings highlight the need for more data on long-term outcomes in various types of donors with potential morbidities related to donation... - Obesity and outcome following renal transplantationJ L Gore
Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Am J Transplant 6:357-63. 2006..001). Donor BMI did not affect overall graft survival (p > or = 0.07). Recipient obesity is associated with an increased risk of DGF and decreased graft survival following renal transplantation... - Recommendations for the outpatient surveillance of renal transplant recipients. American Society of TransplantationB L Kasiske
Division of Nephrology, Hennepin County Medical Center, University of Minnesota, Minneapolis 55415, USA
J Am Soc Nephrol 11:S1-86. 2000..It is hoped that these guidelines will provide a framework for additional discussion and research that will improve the care of renal transplant recipients... - Cyclosporine microemulsion- and mycophenolate mofetil-related lymphoid aggregates are not associated with acute rejectionC C Nast
Department of Pathology, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
Transplantation 72:251-6. 2001..These lymphocytes may play a role in long-term allograft acceptance... - Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literaturePhuong Thu T Pham
David Geffen School of Medicine at UCLA, Nephrology Division, Kidney and Pancreas Transplantation, Los Angeles, CA, USA
Am J Transplant 5:2565-9. 2005..Recurrent SRC in the allograft may be heralded by multiple clinical markers known to be predictive of severe scleroderma, including progression of diffuse skin thickening, new-onset anemia and cardiac complications... - ABO blood type-incompatible kidney transplantation and access to organsGerald S Lipshutz
Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095 7054, USA
Arch Surg 146:453-8. 2011..To determine whether ABO-incompatible (ABOi) kidney transplantation can be performed safely and result in acceptable posttransplantation outcomes... - Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipientPhuong Thu T Pham
Division of Nephrology, Kidney and Pancreas Transplantation, Department of Medicine, UCLA Medical Center, University of California at Los Angeles, 7 155 Factor Building, 10833 LeConte Avenue, Los Angeles, CA 90095, USA
Transplantation 74:1077-80. 2002..A similar mechanism occurring in patients who develop TMA after renal transplantation has not been described... - Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS databaseSuphamai Bunnapradist
Kidney Pancreas Transplant Program, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
J Am Soc Nephrol 14:208-13. 2003..This observation was explained by favorable donor and recipient factors in the SPK group. After controlling for these factors, SPK provided no protective or detrimental effect on short-term renal allograft or patient survival... - Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS databaseJagbir Gill
David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Transplantation 85:62-8. 2008..There are limited data comparing outcomes of DKT to single kidney ECD transplants, making it unclear where DKT fits in the current allocation scheme. Our purpose was to compare outcomes of DKT and ECD transplants in the United States... - Is there a reversal of reverse epidemiology in renal transplant recipients?Disaya Chavalitdhamrong
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA
Semin Dial 20:544-8. 2007..Because definitive evidence on optimal intervention is lacking, population-specific clinical trials are needed to define optimum targets for treatment of these risk factors in maintenance dialysis patients and RTR separately... - Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allograftsJeffrey L Veale
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Hum Immunol 67:777-86. 2006..This study suggests that perforin and granzyme-B gene expressions in peripheral blood are accurate in detecting both cellular and antibody-mediated rejection... - Sirolimus-associated pulmonary toxicityPhuong Thu T Pham
David Geffen School of Medicine at UCLA, Nephrology Division, Kidney and Pancreas Transplantation, Los Angeles, CA 90095, USA
Transplantation 77:1215-20. 2004..Pulmonary toxicity has recently been recognized as a potentially serious complication associated with sirolimus therapy. We further detail this condition on the basis of our own cases and those reported in the literature... - Cardiovascular disease posttransplantPhuong Thu T Pham
Division of Nephrology, Kidney and Pancreas Transplantation, Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
Semin Nephrol 27:430-44. 2007..We provide an overview of the literature on conventional and unconventional cardiovascular disease risk factors after renal transplantation, and discuss an approach to their medical management... - Chain transplantation: initial experience of a large multicenter programM L Melcher
Department of Surgery, Stanford University, CA, USA
Am J Transplant 12:2429-36. 2012..The mean 1-year creatinine of the first 100 transplants from this series was 1.3 mg/dL. Chain transplantation enables many recipients with immunologically incompatible donors to be transplanted with high quality grafts... - The use of executed prisoners as a source of organ transplants in China must stopG M Danovitch
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Am J Transplant 11:426-8. 2011..The relative advantages and drawbacks of these strategies are discussed together with some practical suggestions for response available to individuals and the transplant community... - Long-term analysis of combined liver and kidney transplantation at a single centerRichard Ruiz
Department of Surgery, Dumont-UCLA Transplant Center, University of California, Los Angeles, USA
Arch Surg 141:735-41; discussion 741-2. 2006..Second, CLKT for hepatorenal syndrome is indicated in patients receiving hemodialysis for longer than 8 weeks and confers advantages in patient survival and use of hospital resources. Third, the liver is immunoprotective for the kidney... - Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative diseaseP-T T Pham
Division of Nephrology, Kidney, and Pancreas Transplantation, Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA
Transplant Proc 34:1178-81. 2002 - Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunctionQiuheng Zhang
UCLA Immunogenetics Center, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Transplantation 79:591-8. 2005..Our findings indicate that prospective monitoring for anti-HLA antibodies following transplantation is a useful test for the diagnosis and classification of AHR for identifying patients at risk of early graft dysfunction... - Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc groupAndrew D Bostom
Department of Surgery, University of Minnesota, MMC-328 Mayo, Minneapolis 55455, USA
Am J Transplant 2:491-500. 2002 - Allocating deceased donor kidneys: maximizing years of lifeGabriel M Danovitch
Am J Kidney Dis 49:180-2. 2007 - Waiting time or wasted time? The case for using time on dialysis to determine waiting time in the allocation of cadaveric kidneysGabriel M Danovitch
Am J Transplant 2:891-3. 2002 - The doctor-patient relationship in living donor kidney transplantationGabriel M Danovitch
Curr Opin Nephrol Hypertens 16:503-5. 2007..SUMMARY: Commercialization of transplantation undermines the therapeutic doctor-patient relationship and threatens the healthy development of the international transplant endeavor... - Regulated market for organs is unattainableFrancis L Delmonico
Minn Med 91:6. 2008 - The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference ReportPatricia L Adams
Wake Forest University School of Medicine, USA
Transplantation 74:582-9. 2002..Transplant centers that accept NDD should document an informed consent process that details donor risks, assures donor safety, and determines that the goals and expectations of the NDD and the recipient can be realized... - From Helsinki to Istanbul: what can the transplant community learn from experience in clinical research?Gabriel M Danovitch
Nephrol Dial Transplant 23:1089-92. 2008 - The report of a national conference on the wait list for kidney transplantationRobert S Gaston
Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
Am J Transplant 3:775-85. 2003..Each work group outlined problems and potential remedies within each area. This report summarized the issues and recommendations regarding the waiting list for kidney transplantation addressed in the Philadelphia meeting... - Guidelines on the firing-lineGabriel M Danovitch
Am J Transplant 3:514-5. 2003 - Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters
Shands Jacksonville Transplant Center, Jacksonville, FL, USA
Transplantation 78:537-43. 2004..Immunosuppression-related physical changes remain underaddressed; effective interventions offer opportunities for improved care...